UK markets open in 6 hours 27 minutes

Acarix AB (publ) (ACARIX.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
0.8300-0.0100 (-1.19%)
At close: 05:29PM CET
Full screen
Previous close0.8400
Open0.8390
Bid0.8150 x 0
Ask0.8230 x 0
Day's range0.8000 - 0.8390
52-week range0.7647 - 2.1950
Volume159,494
Avg. volume901,433
Market cap126.608M
Beta (5Y monthly)2.68
PE ratio (TTM)N/A
EPS (TTM)-0.3330
Earnings date16 Feb 2022 - 21 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.40
  • Globe Newswire

    Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

    Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acarix AB ("Acarix" or the "Company") resolved on 23 November 2021 to carry out a new share issue with preferential rights for the Company's existing shareholders at a subscription price of SEK 0.75, which may provide the Company with approximately SEK 79.3 million before deduction of cost related to the rights issue (the "Rights Issue"). The board of directors of Acar

  • Globe Newswire

    Announcement from Acarix's extra general meeting

    Press release Malmö, November 23, 2021 Announcement from Acarix's extra general meeting The extra general meeting of Acarix AB ("Acarix" or the "Company") was held today on 23 November 2021 and the following resolutions were passed by the meeting. RESOLUTION TO APPROVE THE BOARD OF DIRECTORS RESOLUTION ON A RIGHTS ISSUEThe extra general meeting resolved to approve the board of directors resolution from 5 November 2021 regarding a rights issue of a maximum of 105,784,077 shares. The total increas

  • Globe Newswire

    Acarix AB (publ) publishes Interim Report, January – September 2021

    Press release Malmö, November 11, 2021 Acarix AB (publ) publishes Interim Report, January – September 2021 Positive trend and new share issue allow us to accelerate rate of expansion It looks more promising for Acarix in the US market. At the end of October, we obtained a CPT code from the American Medical Association (AMA). The CPT code means the FDA-cleared CADScor®System can be reimbursed by the US social insurance system. We were awarded the code after careful evaluation by the AMA and on th